MacroGenics | Lånekapital



Loan Capital Endring Dato
AbbVie USD 60.34B 1.83B 2024-12
Amgen USD 56.55B 305M 2024-12
AstraZeneca USD 27.73B 2.29B 2024-12
Biogen USD 4.55B 1.4M 2024-12
Bristol-Myers Squibb USD 47.6B 1.07B 2024-12
Daiichi Sankyo JPY 101.03B 95M 2024-12
Eli Lilly USD 28.53B 518.3M 2024-12
Genmab DKK 937M 41M 2024-12
Geron USD 118.48M 106.2M 2024-12
Gilead Sciences USD 24.9B 3.46B 2024-12
J&J USD 30.65B 638M 2024-12
MacroGenics USD 0 0 2024-12
Merck USD 34.46B 520M 2024-12
Pfizer USD 57.4B 597M 2024-12
Regeneron Pharmaceuticals USD 2.7B 720.4M 2024-12
Roche Holding CHF 32.1B 1.94B 2024-12
Xencor USD 115.16M 104.99M 2024-12



MacroGenics Lånekapital - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.